These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 10375169)

  • 1. Antihyperlipidemic action of Ogi-Keishi-Gomotsu-To-Ka-Kojin against cyclophosphamide-induced hyperlipidemia in rabbits.
    Inoue M; Wu CZ; Ogihara Y
    Biol Pharm Bull; 1999 May; 22(5):486-90. PubMed ID: 10375169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihyperlipidemic action of a Traditional Chinese Medicine (kampo medicine), Ogi-Keishi-Gomotsu-To-Ka-Kojin.
    Wu CZ; Inoue M; Ogihara Y
    Phytomedicine; 1997 Dec; 4(4):295-300. PubMed ID: 23195577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repression of acyl-CoA:cholesterol acyltransferase by a traditional herbal medicine (Kampo medicine), Ogi-Keishi-Gomotsu-To-Ka-Kojin.
    Wu CZ; Inoue M; Ogihara Y
    Biol Pharm Bull; 1999 Sep; 22(9):994-6. PubMed ID: 10513630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypercholesterolemic action of a traditional Chinese medicine (Kampo medicine), Ogi-Keishi-Gomotsu-To-Ka-Kojin.
    Wu CZ; Inoue M; Ogihara Y
    Biol Pharm Bull; 1998 Dec; 21(12):1311-6. PubMed ID: 9881645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein lipase activation by red ginseng saponins in hyperlipidemia model animals.
    Inoue M; Wu CZ; Dou DQ; Chen YJ; Ogihara Y
    Phytomedicine; 1999 Oct; 6(4):257-65. PubMed ID: 10589445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein lipase regulation in the cyclophosphamide-treated rabbit: dependence on nutritional status.
    Lespine A; Azema C; Gafvels M; Manent J; Dousset N; Chap H; Perret B
    J Lipid Res; 1993 Jan; 34(1):23-36. PubMed ID: 8445340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired secretion of heart lipoprotein lipase in cyclophosphamide-treated rabbit.
    Lespine A; Chap H; Perret B
    Biochim Biophys Acta; 1997 Mar; 1345(1):77-85. PubMed ID: 9084504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial lipoprotein lipase activity: regulation by diabetes and fructose-induced hypertriglyceridemia.
    Liu L; Severson DL
    Can J Physiol Pharmacol; 1995 Mar; 73(3):369-77. PubMed ID: 7648516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac heparin-releasable lipoprotein lipase activity in fructose-hypertensive rats: effect of coronary vasodilation.
    Sambandam N; Lim F; Cam MC; Rodrigues B
    J Cardiovasc Pharmacol; 1997 Jul; 30(1):110-7. PubMed ID: 9268229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of streptozotocin-induced diabetes on cardiac lipoprotein lipase activity.
    Rodrigues B; Cam MC; Jian K; Lim F; Sambandam N; Shepherd G
    Diabetes; 1997 Aug; 46(8):1346-53. PubMed ID: 9231661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postheparin plasma lipoprotein lipase and hepatic lipase in diabetes mellitus. Relationship to plasma triglyceride metabolism.
    Nikkilä EA; Huttunen JK; Ehnholm C
    Diabetes; 1977 Jan; 26(1):11-21. PubMed ID: 187516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of diet on adipose tissue and skeletal muscle VLDL receptor and LPL: implications for obesity and hyperlipidemia.
    Roberts CK; Barnard RJ; Liang KH; Vaziri ND
    Atherosclerosis; 2002 Mar; 161(1):133-41. PubMed ID: 11882325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphatidylinositol-specific phospholipase C releases lipoprotein lipase from the heparin releasable pool in rat heart cell cultures.
    Chajek-Shaul T; Halimi O; Ben-Naim M; Stein O; Stein Y
    Biochim Biophys Acta; 1989 Nov; 1014(2):178-83. PubMed ID: 2554975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex- and age-related variations in the in vitro heparin-releasable lipoprotein lipase from mononuclear leukocytes in blood.
    Maehira F; Miyagi I; Eguchi Y
    Biochim Biophys Acta; 1990 Feb; 1042(3):344-51. PubMed ID: 2106346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The lipoprotein lipase system: new understandings.
    Tan MH
    Can Med Assoc J; 1978 Mar; 118(6):675-80. PubMed ID: 207404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein restriction and AST-120 improve lipoprotein lipase and VLDL receptor in focal glomerulosclerosis.
    Sato T; Liang K; Vaziri ND
    Kidney Int; 2003 Nov; 64(5):1780-6. PubMed ID: 14531811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A transcription-dependent mechanism, akin to that in adipose tissue, modulates lipoprotein lipase activity in rat heart.
    Wu G; Zhang L; Gupta J; Olivecrona G; Olivecrona T
    Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E908-15. PubMed ID: 17595214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic effects of rexinoids: tissue-specific regulation of lipoprotein lipase activity.
    Davies PJ; Berry SA; Shipley GL; Eckel RH; Hennuyer N; Crombie DL; Ogilvie KM; Peinado-Onsurbe J; Fievet C; Leibowitz MD; Heyman RA; Auwerx J
    Mol Pharmacol; 2001 Feb; 59(2):170-6. PubMed ID: 11160850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenovirus-mediated gene transfer of human lipoprotein lipase ameliorates the hyperlipidemias associated with apolipoprotein E and LDL receptor deficiencies in mice.
    Zsigmond E; Kobayashi K; Tzung KW; Li L; Fuke Y; Chan L
    Hum Gene Ther; 1997 Nov; 8(16):1921-33. PubMed ID: 9382958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of NO-1886, a lipoprotein lipase promoting agent, on homozygous and heterozygous Watanabe heritable hyperlipidaemic rabbits.
    Tsutsumi K; Inoue Y; Murase T
    Arzneimittelforschung; 2000 Feb; 50(2):118-21. PubMed ID: 10719613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.